8 12, 2016 Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications Diatech Pharmacogenetics2016-12-08T17:27:27+01:00 Read More
